Evidence map›Paper›PMID 31424170›Full record

ArticlePediatric pulmonology2019

Clinical significance of the bronchodilator response in children with severe asthma.

Andrea M Coverstone, Leonard B Bacharier, Bradley S Wilson, Anne M Fitzpatrick, William Gerald Teague, Wanda Phipatanakul, Sally E Wenzel, Benjamin M Gaston, Eugene R Bleecker, Wendy C Moore and 9 more

Open access · greenAbstract read
In one paragraph

Article in Pediatric pulmonology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Bronchodilator response is linked with uncontrolled moderate-to-severe childhood asthma and elevated IL-4 and IL-13.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Type 2 inflammation in the sputum of adolescents with asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 1 country.

Andrea M CoverstoneDepartment of Pediatrics, Washington University School of Medicine in Saint Louis, St. Louis, Missouri.ORCID 0000-0002-9666-4885
Leonard B BacharierDepartment of Pediatrics, Washington University School of Medicine in Saint Louis, St. Louis, Missouri.
Bradley S WilsonDepartment of Ophthalmology and Visual Sciences, Washington University School of Medicine in Saint Louis, St. Louis, Missouri.
Anne M FitzpatrickDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
William Gerald TeagueDepartment of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia.
Wanda PhipatanakulDepartment of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Sally E WenzelDepartment of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Benjamin M GastonDepartment of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, Ohio.
Eugene R BleeckerDepartment of Medicine, University of Arizona, Tucson, Arizona.
Wendy C MooreDepartment of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Sima RamratnamDepartment of Pediatrics, University of Wisconsin School of Medicine, Madison, Wisconsin.
Nizar N JarjourDepartment of Medicine, University of Wisconsin School of Medicine, Madison, Wisconsin.
Ngoc P LyDepartment of Pediatrics, University of California, San Francisco, San Francisco, California.
John V FahyDepartment of Medicine, University of California, San Francisco, San Francisco, California.
David T MaugerDepartment of Public Health Sciences, Pennsylvania State University, Hershey, Pennsylvania.
Kenneth B SchechtmanDepartment of Medicine, Washington University School of Medicine in Saint Louis, St. Louis, Missouri.
Huiqing Yin-DeClueDepartment of Medicine, Washington University School of Medicine in Saint Louis, St. Louis, Missouri.
Jonathan S BoomerDepartment of Medicine, Washington University School of Medicine in Saint Louis, St. Louis, Missouri.
Mario CastroDepartment of Medicine, Washington University School of Medicine in Saint Louis, St. Louis, Missouri.
Washington University in St. Louis · USUniversity of California, San Francisco · USUniversity of Wisconsin–Madison · USBoston Children's Hospital · USEmory University · USPennsylvania State University · USRainbow Babies & Children's Hospital · USUniversity of Arizona · USUniversity of Pittsburgh · USUniversity of Virginia · USWake Forest University · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Clinical Coordinating Center for the Severe Asthma Research Program (SARP)U10HL109086 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MAUGER, DAVID T. · 2011 to 2017
$8.1M
AMSA: ALXR/FBR Mediated Signaling in Severe AsthmaU10HL109172 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ISRAEL, ELLIOT, LEVY, BRUCE D · 2011 to 2016
$4.2M
Airway redox biochemistry as a deteriminant of asthma phenotype during adolescen*U10HL109250 · NHLBI · UNIVERSITY OF VIRGINIA · PI ERZURUM, SERPIL C., GASTON, BENJAMIN · 2011 to 2016
$4.2M
Clinical and Molecular Phenotypes of Severe AsthmaU10HL109146 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FAHY, JOHN V · 2011 to 2016
$4.0M
Implications and Stability of Clinical and Molecular Phenotypes of Severe AsthmaU10HL109152 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WENZEL, SALLY E · 2011 to 2016
$3.9M
Stability of Severe Asthma Phenotypes: Impact of ExacerbationsU10HL109168 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI JARJOUR, NIZAR N · 2011 to 2016
$3.9M
Severe Asthma Research Program (SARP)-Washington UniversityU10HL109257 · NHLBI · WASHINGTON UNIVERSITY · PI CASTRO, MARIO · 2011 to 2016
$3.8M
Longitudinal Phenomics and Genetics of Severe AsthmaU10HL109164 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BLEECKER, EUGENE ROLAND, MEYERS, DEBORAH A. · 2011 to 2016
$3.8M
NCATS NIH HHS 5UL1 TR000448NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NHLBI NIH HHS U10 HL109086NHLBI NIH HHS U10 HL109146NHLBI NIH HHS U10 HL109152NHLBI NIH HHS U10 HL109164NHLBI NIH HHS U10 HL109168NHLBI NIH HHS U10 HL109172NHLBI NIH HHS U10 HL109250NHLBI NIH HHS U10 HL109257
6 · The paper itself

Abstract

backgroundOur objective was to determine those characteristics associated with reversibility of airflow obstruction and response to maximal bronchodilation in children with severe asthma through the Severe Asthma Research Program (SARP).

methodsWe performed a cross-sectional analysis evaluating children ages 6 to 17 years with nonsevere asthma (NSA) and severe asthma (SA). Participants underwent spirometry before and after 180 µg of albuterol to determine reversibility (≥12% increase in FEV

resultsWe evaluated 230 children (n = 129 SA, n = 101 NSA) from five centers across the United States in the SARP I and II cohorts. SA (odds ratio [OR], 2.08, 95% confidence interval [CI], 1.05-4.13), second-hand smoke exposure (OR, 2.81, 95%CI, 1.23-6.43), and fractional exhaled nitric oxide (FeNO; OR, 1.97, 95%CI, 1.35-2.87) were associated with increased odds of airway reversibility after maximal bronchodilation, while higher prebronchodilator (BD) FEV

conclusionsLung function, that is FEV

Indexed as

AdolescentAlbuterolAsthmaBreath TestsBronchodilator AgentsChildCohort StudiesCross-Sectional StudiesDose-Response Relationship, DrugFemaleForced Expiratory VolumeHumansImmunoglobulin ELungMaleNitric OxideAlbuterolBronchodilator AgentsImmunoglobulin ENitric Oxideasthmabronchodilator responsepediatrics

Identifiers

PMID31424170
PMCPMC7015037
OpenAlexW2969998211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.